Keller MJ - Search Results

1

Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.

Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B, Garforth SJ, Herrera NG, Jangra RK, Morano NC, Orner E, Sy S, Chandran K, Dziura J, Almo SC, Ring A, Keller MJ, Herold KC, Herold BC. Pierce CA, et al. Among authors: keller mj. Sci Transl Med. 2020 Oct 7;12(564):eabd5487. doi: 10.1126/scitranslmed.abd5487. Epub 2020 Sep 21. Sci Transl Med. 2020. PMID: 32958614 Free PMC article.

2

Rigorous pre-clinical evaluation of topical microbicides to prevent transmission of human immunodeficiency virus.

Keller MJ, Klotman ME, Herold BC. Keller MJ, et al. J Antimicrob Chemother. 2003 May;51(5):1099-102. doi: 10.1093/jac/dkg214. Epub 2003 Apr 14. J Antimicrob Chemother. 2003. PMID: 12697652 Review. No abstract available.

3

Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus.

Keller MJ, Klotman ME, Herold BC. Keller MJ, et al. Am J Reprod Immunol. 2003 May;49(5):279-84. doi: 10.1034/j.1600-0897.2003.00044.x. Am J Reprod Immunol. 2003. PMID: 12854732 Review.

4

Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.

Cheshenko N, Keller MJ, MasCasullo V, Jarvis GA, Cheng H, John M, Li JH, Hogarty K, Anderson RA, Waller DP, Zaneveld LJ, Profy AT, Klotman ME, Herold BC. Cheshenko N, et al. Among authors: keller mj. Antimicrob Agents Chemother. 2004 Jun;48(6):2025-36. doi: 10.1128/AAC.48.6.2025-2036.2004. Antimicrob Agents Chemother. 2004. PMID: 15155195 Free PMC article.

5

Topical microbicides for the prevention of genital herpes infection.

Keller MJ, Tuyama A, Carlucci MJ, Herold BC. Keller MJ, et al. J Antimicrob Chemother. 2005 Apr;55(4):420-3. doi: 10.1093/jac/dki056. Epub 2005 Mar 2. J Antimicrob Chemother. 2005. PMID: 15743896 Review.

6

Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection.

John M, Keller MJ, Fam EH, Cheshenko N, Hogarty K, Kasowitz A, Wallenstein S, Carlucci MJ, Tuyama AC, Lu W, Klotman ME, Lehrer RI, Herold BC. John M, et al. Among authors: keller mj. J Infect Dis. 2005 Nov 15;192(10):1731-40. doi: 10.1086/497168. Epub 2005 Oct 13. J Infect Dis. 2005. PMID: 16235171

7

PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.

Keller MJ, Zerhouni-Layachi B, Cheshenko N, John M, Hogarty K, Kasowitz A, Goldberg CL, Wallenstein S, Profy AT, Klotman ME, Herold BC. Keller MJ, et al. J Infect Dis. 2006 Jan 1;193(1):27-35. doi: 10.1086/498533. Epub 2005 Nov 17. J Infect Dis. 2006. PMID: 16323128 Clinical Trial.

8

Role of mucosal immunity in preventing genital herpes infection.

MasCasullo V, Fam E, Keller MJ, Herold BC. MasCasullo V, et al. Among authors: keller mj. Viral Immunol. 2005;18(4):595-606. doi: 10.1089/vim.2005.18.595. Viral Immunol. 2005. PMID: 16359226 Review.

9

Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.

Madan RP, Keller MJ, Herold BC. Madan RP, et al. Among authors: keller mj. Curr Opin Infect Dis. 2006 Feb;19(1):49-54. doi: 10.1097/01.qco.0000200291.37909.3b. Curr Opin Infect Dis. 2006. PMID: 16374218 Review.

10

ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations.

Tuyama AC, Cheshenko N, Carlucci MJ, Li JH, Goldberg CL, Waller DP, Anderson RA, Profy AT, Klotman ME, Keller MJ, Herold BC. Tuyama AC, et al. Among authors: keller mj. J Infect Dis. 2006 Sep 15;194(6):795-803. doi: 10.1086/506948. Epub 2006 Aug 16. J Infect Dis. 2006. PMID: 16941346

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page